{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:18:49Z","timestamp":1761110329556},"reference-count":40,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Interleukin 33 (IL-33), a member of the IL-1 family and a ligand of the orphan receptor ST2, plays key roles in innate and adaptive immunity. We examined the associations between IL-33\/ST2 levels and clinical manifestations of patients with active adult-onset Still\u2019s disease (AOSD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Blood samples were collected from 40 patients with active AOSD, 28 patients with rheumatoid arthritis (RA), and 27 healthy controls (HC). The serum levels of IL-33 and soluble ST2 were determined using ELISA. Expression levels of IL-33 and ST2 in biopsy specimens obtained from 34 AOSD patients with rash were immunohistochemically investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>IL-33 levels of patients with AOSD were higher than those of patients with RA and HC. Soluble ST2 levels of patients with AOSD were higher than those of HC, but not of patients with RA. Serum IL-33 levels correlated with systemic score, erythrocyte sedimentation rate, ferritin levels, and aspartate transaminase levels. However, serum soluble ST2 levels correlated only with ferritin levels. The numbers of inflammatory cells expressing IL-33 and ST2 were elevated in skin lesions of patients with AOSD compared to HC, but did not differ from those of the skin lesions of eczema or psoriasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>We found significantly higher serum IL-33 and soluble ST2 levels in patients with active AOSD. Results indicate that the IL-33\/ST2 signaling pathway may play a role in the pathogenesis of the acute inflammation and skin manifestations associated with AOSD.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.170020","type":"journal-article","created":{"date-parts":[[2017,4,2]],"date-time":"2017-04-02T00:20:15Z","timestamp":1491092415000},"page":"740-747","source":"Crossref","is-referenced-by-count":18,"title":["Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still\u2019s Disease"],"prefix":"10.3899","volume":"44","author":[{"given":"Jae Ho","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Yang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunee","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2017,4,1]]},"reference":[{"key":"2018112909370426000_44.6.740.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.058"},{"key":"2018112909370426000_44.6.740.2","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909370426000_44.6.740.3","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still\u2019s disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909370426000_44.6.740.4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050640"},{"key":"2018112909370426000_44.6.740.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket250"},{"key":"2018112909370426000_44.6.740.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.09.015"},{"key":"2018112909370426000_44.6.740.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003331"},{"key":"2018112909370426000_44.6.740.8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2018112909370426000_44.6.740.9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/cmi.2016.34","article-title":"HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins","volume":"14","author":"Bertheloot","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"2018112909370426000_44.6.740.10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M704916200"},{"key":"2018112909370426000_44.6.740.11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140234"},{"key":"2018112909370426000_44.6.740.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090492"},{"key":"2018112909370426000_44.6.740.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep402"},{"key":"2018112909370426000_44.6.740.14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12876-016-0520-6","article-title":"Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution","volume":"16","author":"Diaz-Jimenez","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"2018112909370426000_44.6.740.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.03.007"},{"key":"2018112909370426000_44.6.740.16","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.3390\/ijms17081342","article-title":"TLR4 endogenous ligand S100A8\/A9 levels in adult-onset Still\u2019s disease and their association with disease activity and clinical manifestations","volume":"17","author":"Kim","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2018112909370426000_44.6.740.17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s10067-016-3314-x","article-title":"Elevated high-mobility group B1 levels in active adult-onset Still\u2019s disease associated with systemic score and skin rash","volume":"35","author":"Jung","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2018112909370426000_44.6.740.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140651"},{"key":"2018112909370426000_44.6.740.19","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"2018112909370426000_44.6.740.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"2018112909370426000_44.6.740.21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine"},{"key":"2018112909370426000_44.6.740.22","doi-asserted-by":"crossref","first-page":"985301","DOI":"10.1155\/2013\/985301","article-title":"Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis","volume":"2013","author":"Tang","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2018112909370426000_44.6.740.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.12.010"},{"key":"2018112909370426000_44.6.740.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.02.011"},{"key":"2018112909370426000_44.6.740.25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100184"},{"key":"2018112909370426000_44.6.740.26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3346\/jkms.2011.26.9.1132","article-title":"Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis","volume":"26","author":"Hong","year":"2011","journal-title":"J Korean Med Sci"},{"key":"2018112909370426000_44.6.740.27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2015.02.001","article-title":"IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study","volume":"45","author":"Shen","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2018112909370426000_44.6.740.28","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909370426000_44.6.740.29","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22194"},{"key":"2018112909370426000_44.6.740.30","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20319"},{"key":"2018112909370426000_44.6.740.31","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.446"},{"key":"2018112909370426000_44.6.740.32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00403-016-1638-7","article-title":"Interleukin-33: increasing role in dermatological conditions","volume":"308","author":"Balato","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"2018112909370426000_44.6.740.33","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041360"},{"key":"2018112909370426000_44.6.740.34","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.85"},{"key":"2018112909370426000_44.6.740.35","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12027"},{"key":"2018112909370426000_44.6.740.36","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12272"},{"key":"2018112909370426000_44.6.740.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.04.014"},{"key":"2018112909370426000_44.6.740.38","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1097\/MD.0000000000000787","article-title":"The pathologic findings of skin, lymph node, liver, and bone marrow in patients with adult-onset still disease: a comprehensive analysis of 40 cases","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine"},{"key":"2018112909370426000_44.6.740.39","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPZE77UAPSMDCD"},{"key":"2018112909370426000_44.6.740.40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq284"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.170020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:16:31Z","timestamp":1543518991000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.170020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,1]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3899\/jrheum.170020"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.170020","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,1]]}}}